GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSource Co Ltd (TSE:4880) » Definitions » EV-to-EBITDA

CellSource Co (TSE:4880) EV-to-EBITDA : 19.98 (As of May. 22, 2024)


View and export this data going back to 2019. Start your Free Trial

What is CellSource Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, CellSource Co's enterprise value is 円22,252 Mil. CellSource Co's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was 円1,114 Mil. Therefore, CellSource Co's EV-to-EBITDA for today is 19.98.

The historical rank and industry rank for CellSource Co's EV-to-EBITDA or its related term are showing as below:

TSE:4880' s EV-to-EBITDA Range Over the Past 10 Years
Min: 15.09   Med: 71.59   Max: 301.97
Current: 19.98

During the past 7 years, the highest EV-to-EBITDA of CellSource Co was 301.97. The lowest was 15.09. And the median was 71.59.

TSE:4880's EV-to-EBITDA is ranked worse than
65.7% of 449 companies
in the Biotechnology industry
Industry Median: 9.97 vs TSE:4880: 19.98

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-22), CellSource Co's stock price is 円1360.00. CellSource Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was 円43.920. Therefore, CellSource Co's PE Ratio for today is 30.97.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


CellSource Co EV-to-EBITDA Historical Data

The historical data trend for CellSource Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellSource Co EV-to-EBITDA Chart

CellSource Co Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
EV-to-EBITDA
Get a 7-Day Free Trial 44.13 114.92 113.34 48.49 23.43

CellSource Co Quarterly Data
Oct18 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.60 25.46 22.75 23.43 18.01

Competitive Comparison of CellSource Co's EV-to-EBITDA

For the Biotechnology subindustry, CellSource Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellSource Co's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CellSource Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where CellSource Co's EV-to-EBITDA falls into.



CellSource Co EV-to-EBITDA Calculation

CellSource Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=22252.034/1113.592
=19.98

CellSource Co's current Enterprise Value is 円22,252 Mil.
CellSource Co's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,114 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CellSource Co  (TSE:4880) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

CellSource Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1360.00/43.920
=30.97

CellSource Co's share price for today is 円1360.00.
CellSource Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円43.920.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


CellSource Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of CellSource Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


CellSource Co (TSE:4880) Business Description

Traded in Other Exchanges
N/A
Address
Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002
CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.

CellSource Co (TSE:4880) Headlines

No Headlines